Methods for whole-cell analysis of gram-positive bacteria
AssigneeAdvanDx, Inc.
InventorsHenrik Stender, Jan Trnovsky, Lisa L. Klimas, Anne K.I. Rasmussen
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdvanDx, Inc.
InventorsHenrik Stender, Jan Trnovsky, Lisa L. Klimas, Anne K.I. Rasmussen
Estimating the term…
This application pertains to methods for the whole-cell analysis of gram-positive bacteria. The methods are capable of making a determination of whether or not a sample (e.g., a clinical sample) comprises one or more select gram-positive bacteria as well as, for example, whether or not none, some or all of said select gram-positive bacteria in said sample, or possibly other bacteria in said sample, possess a select trait or traits of interest. In some embodiments, the methods can be used to determine methicillin-resistant (the select trait) staphylococcus aureus (the select gram-positive bacteria), coagulase-negative staphylococci (another select gram-positive bacteria) and/or methicillin-sensitive staphylococcus aureus (MSSA) in said sample. The whole-cell analysis can be performed, for example, by in-situ hybridization (ISH), fluorescence in-situ hybridization (FISH), immunocytochemistry (ICC), or any combination of two or more of the foregoing.
1-58. (canceled)
A composition for identification of methicillin-resistant bacteria in a sample, comprising one or more mRNA-directed peptide nucleic acid (PNA) probes, wherein the one or more PNA probes are selected from the group consisting of SEQ ID Nos. 17-21, 25 and 28-33.
Dependencies are inferred from the claim text.